Climb Bio, Inc. (CLYM)
10.24
-0.64
(-5.84%)
USD |
NASDAQ |
Nov 13, 10:26
Climb Bio Free Cash Flow (Quarterly) : -12.82M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -12.82M |
| June 30, 2026 | -10.81M |
| March 31, 2026 | -14.38M |
| December 31, 2025 | -15.64M |
| September 30, 2025 | -12.25M |
| June 30, 2025 | -11.22M |
| March 31, 2025 | -15.43M |
| December 31, 2024 | -5.521M |
| September 30, 2024 | -7.555M |
| June 30, 2024 | -0.667M |
| March 31, 2024 | -1.819M |
| December 31, 2023 | -0.947M |
| September 30, 2023 | 3.49M |
| Date | Value |
|---|---|
| June 30, 2023 | -7.965M |
| March 31, 2023 | -15.18M |
| December 31, 2022 | -8.449M |
| September 30, 2022 | -4.175M |
| June 30, 2022 | -13.97M |
| March 31, 2022 | -10.78M |
| December 31, 2021 | -7.884M |
| September 30, 2021 | -12.97M |
| June 30, 2021 | -8.481M |
| March 31, 2021 | -6.74M |
| September 30, 2020 | -2.381M |
| June 30, 2020 | -3.768M |
| March 31, 2020 | -2.325M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -47.06M |
| Cullinan Therapeutics, Inc. | -43.08M |
| Q32 Bio, Inc. | -4.47M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Oncolytics Biotech, Inc. | -8.066M |